Evidence-based recommendations for FN syndromes
The ASCO Guidelines17 are not included because they refer specifically to outpatient management and do not offer grading of the recommendations. The Australian guidelines do not specify grading of recommendation for the empirical addition of antifungal agents during FN, but they have published detailed pathogen-specific antifungal management advice.26
IPN indicates International Pediatric Fever and Neutropenia Guideline Panel for the Management of Fever and Neutropenia in Children with Cancer and/or Undergoing Hematopoietic Stem Cell Transplantation; and NA, not addressed. For definitions of the fever and neutropenia syndromes, see text.
*The NCCN guidelines address only prophylaxis; the recommendations in this table are from the online version accessed May 3, 2013 at www.nccn.org.
†The pediatric panel different grading of these recommendations reflects the lack of pediatric-specific data.
